{
  "id": 19973225,
  "title": "Orchid Pharma Posts Consolidated Net Profit Of ₹28.59 Crore In Q2",
  "url": "https://urgent.news/2026/11/14/orchid-pharma-posts-consolidated-net-profit-of-28-59-crore-in-q2",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-14T11:10:31.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/orchid-pharma-posts-consolidated-net-profit-of-2859-crore-in-q2"
  },
  "original_language": "en",
  "account": "Mumbai: Orchid Pharma reported a consolidated net profit of ₹28.59 crore in the second quarter of its 2026-27 fiscal year, according to the company's financial results released on November 14, 2026. The quarter saw a significant rise in consolidated revenue from operations, reaching ₹341.27 crore, up from ₹298.46 crore in the same period last year. Overall income for the quarter also increased to ₹359.02 crore, compared to ₹310.10 crore in the previous quarter. Natco Pharma, meanwhile, announced a sharp decline in its Q2 earnings as profit plummeted 61% to ₹202.6 crore, with revenue falling by 29% and expenses rising.",
  "summary": "Mumbai: Orchid Pharma announced its financial results for the second quarter of the 2026-27 fiscal year on Friday, November 14, 2026. Financial Performance Consolidated revenue from operations stood at ₹341.27 crore for the quarter, marking an increase compared to ₹298.46 crore in the same period last year. Total consolidated income reached ₹359.02 crore, up from ₹310.10 crore recorded in the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}